scholarly article | Q13442814 |
P50 | author | Franco Aversa | Q45309228 |
Elena Masselli | Q56126120 | ||
P2093 | author name string | Marco Vitale | |
Silvia Martini | |||
Prisco Mirandola | |||
Cecilia Carubbi | |||
Daniela Galli | |||
Giuliana Gobbi | |||
Giulia Pozzi | |||
P2860 | cites work | Phorbol ester-induced PKCepsilon down-modulation sensitizes AML cells to TRAIL-induced apoptosis and cell differentiation | Q46260995 |
Timing and expression level of protein kinase C epsilon regulate the megakaryocytic differentiation of human CD34 cells. | Q50897596 | ||
Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis. | Q53166045 | ||
Thrombosis in primary myelofibrosis: incidence and risk factors | Q61050096 | ||
Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes | Q73012008 | ||
Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis | Q77768132 | ||
Dual role of platelet protein kinase C in thrombus formation: stimulation of pro-aggregatory and suppression of procoagulant activity in platelets | Q79517819 | ||
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment | Q79802927 | ||
Risk stratification of patients with acute myocardial infarction by quantification of circulating monocyte-platelet aggregates | Q79838195 | ||
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia | Q27853375 | ||
Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera | Q28174281 | ||
Differential roles of the PKC novel isoforms, PKCdelta and PKCepsilon, in mouse and human platelets | Q33386819 | ||
Protein kinase C ε expression in platelets from patients with acute myocardial infarction | Q34447109 | ||
Mechanisms of thrombus formation | Q34815800 | ||
Platelet receptors and signaling in the dynamics of thrombus formation. | Q37175605 | ||
Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics | Q37608910 | ||
Protein kinase Cε as a cancer marker and target for anticancer therapy | Q37858343 | ||
Arterial thrombus formation in cardiovascular disease | Q37897474 | ||
Protein kinase C ε in hematopoiesis: conductor or selector? | Q38069796 | ||
Myeloproliferative neoplasms and thrombosis. | Q38119076 | ||
Cytofluorimetric platelet analysis. | Q38175007 | ||
Hypoxia-induced down-modulation of PKCepsilon promotes trail-mediated apoptosis of tumor cells. | Q39674856 | ||
Human thrombopoiesis depends on Protein kinase Cδ/protein kinase Cε functional couple | Q39849058 | ||
Regulation of outside-in signaling in platelets by integrin-associated protein kinase C beta | Q40493902 | ||
Protein kinase Cɛ inhibition restores megakaryocytic differentiation of hematopoietic progenitors from primary myelofibrosis patients | Q40727272 | ||
Assessment of platelet activation in myeloproliferative disorders with complementary techniques | Q44827234 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 13 | |
P921 | main subject | myelofibrosis | Q1752571 |
P304 | page(s) | 273 | |
P577 | publication date | 2017-07-01 | |
P1433 | published in | Annals of Translational Medicine | Q26842362 |
P1476 | title | Platelet expression of PKCepsilon oncoprotein in myelofibrosis is associated with disease severity and thrombotic risk | |
P478 | volume | 5 |
Q38649543 | Cancer diagnostics: current concepts and future perspectives |
Q61796079 | Combination of Platelet expression of PKCepsilon and cardiac troponin-I for early diagnosis of chest pain patients in the emergency department |
Q88138812 | The -2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severity |
Search more.